Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Jul 6, 2023
Open Peer Review Period: Jul 6, 2023 - Aug 31, 2023
Date Accepted: Feb 1, 2024
(closed for review but you can still tweet)
Feasibility of monitoring AYA cancer patients with a smart t-shirt: Results from the OncoSmartShirt study
ABSTRACT
Background:
Wearables can be potential tools for supportive care during cancer treatment. However, knowledge of the use of wearables for symptom monitoring during cancer treatment is limited, and consensus and awareness about compliance or adherence are sparse.
Objective:
The aim of this study was to evaluate the adherence and patient experience of using a smart t-shirt for remote monitoring of biometric sensor data in adolescents and young adults (AYA) undergoing cancer treatment during a two-week period.
Methods:
The study was a prospective, single-cohort, mixed-method feasibility study. Inclusion criteria were patients ≥18-39 years receiving treatment at Copenhagen University Hospital, Rigshospitalet, D.K. Consenting patients were asked to wear the ChronolifeTM smart t-shirt for a period of two weeks. The smart t-shirt has multiple sensors and electrodes, which engender six measurements; ECG, thoracic and abdominal respiration, thoracic impedance, physical activity (steps), and skin temperature. The primary endpoint was adherence, defined as wear time > 8 hours/day. The patient experience was investigated in individual semi-structured interviews and a questionnaire.
Results:
Ten patients were included. Wear time >8 h/d during the study period (14 days) varied between 0-6 days, mean 2 days. Three patients had a mean wear time >8 h/d during their days with data registration. Days with any data registration were 0-10, mean 6.4 days. Thematic analysis of interviews pointed at three main themes: 1) The smart t-shirt is cool but does not fit cancer patients; 2) The technique limits the use of the smart t-shirt; and 3) Monitoring of data increases the safety feeling. Results from the questionnaire showed that the patients generally had confidence in the product.
Conclusions:
Although the primary endpoint was not reached, the patients' experience using the smart t-shirt led to the knowledge that patients acknowledged the need for new technologies for improved supportive care in cancer. The patients were positive when asked to wear the smart t-shirt. However, technical and practical challenges in using the device led to low adherence. Although wearables might have a potential for home monitoring, the present technology is immature for clinical use. Clinical Trial: NCT05235594
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.